Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Godfrey

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Blood|March 14, 2024
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphomaJames K Godfrey, Lei Gao, Geoffrey Shouse, et al.
Cell Genomics|August 7, 2024
Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses in vivo and in vitro in four human cell typesLaura V Blanton, Adrianna K San Roman, Geryl Wood, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses <i>in vivo</i> and <i>in vitro</i> in four human cell typesLaura V Blanton, Adrianna K San Roman, Geryl Wood, et al.
Clinical Epigenetics|January 16, 2024
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylationLaura K Godfrey, Jan Forster, Sven-Thorsten Liffers, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphomaSravya Tumuluru, James K Godfrey, Alan Cooper, et al.
Blood Advances|July 28, 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCLKirk E Cahill, James K Godfrey, Chadi Nabhan, et al.
Blood|January 27, 2025
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody responseSravya Tumuluru, James K Godfrey, Alan Cooper, et al.
Blood Advances|October 8, 2025
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetrationLei Gao, Avyakta Kallam, Geoffrey Shouse, et al.
Nature Communications|May 5, 2026
Human brain changes after first psilocybin useT Lyons, M Spriggs, L Kerkelä, et al.
Cell Genomics|February 23, 2023
The human inactive X chromosome modulates expression of the active X chromosomeAdrianna K San Roman, Alexander K Godfrey, Helen Skaletsky, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Blood|March 14, 2024
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphomaJames K Godfrey, Lei Gao, Geoffrey Shouse, et al.
Cell Genomics|August 7, 2024
Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses in vivo and in vitro in four human cell typesLaura V Blanton, Adrianna K San Roman, Geryl Wood, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses <i>in vivo</i> and <i>in vitro</i> in four human cell typesLaura V Blanton, Adrianna K San Roman, Geryl Wood, et al.
Clinical Epigenetics|January 16, 2024
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylationLaura K Godfrey, Jan Forster, Sven-Thorsten Liffers, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphomaSravya Tumuluru, James K Godfrey, Alan Cooper, et al.
Blood Advances|July 28, 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCLKirk E Cahill, James K Godfrey, Chadi Nabhan, et al.
Blood|January 27, 2025
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody responseSravya Tumuluru, James K Godfrey, Alan Cooper, et al.
Blood Advances|October 8, 2025
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetrationLei Gao, Avyakta Kallam, Geoffrey Shouse, et al.
Nature Communications|May 5, 2026
Human brain changes after first psilocybin useT Lyons, M Spriggs, L Kerkelä, et al.
Cell Genomics|February 23, 2023
The human inactive X chromosome modulates expression of the active X chromosomeAdrianna K San Roman, Alexander K Godfrey, Helen Skaletsky, et al.
Pageof 15